• All News
• ADHD Home

ADHD News

• Celebrity Designer and ADHD Spokesperson Ty Pennington Partners with Shire to Announce the Launch of VYVANSE for the Treatment of ADHD in Adults
  published on Tue, 22 July 2008 10:15:00 EST
• Results of the Phase III Pivotal Study of VYVANSE™ for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists VYVANSE demonstrated significant improvement in ADHD symptoms in adults
  published on Thu, 08 May 2008 11:16:00 EST
• New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA™, Offered ADHD Symptom Control for 12 Months
  published on Wed, 07 May 2008 15:33:00 EST
• Shire’s Investigational Nonstimulant ADHD Treatment INTUNIV™ Demonstrated Significant Efficacy in Reducing ADHD Symptoms At All Measured Time Points Up To 24 Hours Postdose
  published on Wed, 07 Mayu 2008 15:33:00 EST
• FDA Approves VYVANSE™, the First and Only Once-Daily Prodrug Stimulant to Treat ADHD in Adults
  published on Wed, 23 Apr 2008 00:09:00 EST
• FW: Published Study Shows Vyvanse Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours
  published on Thu, 29 Nov 2007 00:09:00 EST
• Results of a Survey of Parents’ Perceptions of the Duration of their Child’s ADHD Medication Reported at Medical Meeting
  published on Fri, 09 Nov 2007 00:09:00 EST
• Celebrity Designer Ty Pennington to Host 'ADHD Experts On Call' Program Sept 19, 8am to midnight
  published on Wed, 12 Sep 2007 15:02:00 EDT
• Shire's New ADHD medication, VYVANSE™ Now Available in U.S. Pharmacies Nationwide
  Clinical study demonstrated efficacy until 6pm; May be of interest to mothers of children with ADHD
  published on Fri, 27 Jul 2007 00:00:00 EST
• Shire Receives Approvable Letter from FDA for INTUNIV™ (guanfacine) Extended Release, a Nonstimulant for the treatment of ADHD
  published on Thu, 21 Jun 2007 00:00:00 EST
• Long-term Treatment with VYVANSE™, the First Prodrug Stimulant, Demonstrates Significant Efficacy in Children with ADHD
  published on Wed, 23 May 2007 00:00:00 EST
• Daytrana™ - Provides Significant Effectiveness in ADHD Symptom Relief in Both Boys and Girls
  . published on Wed, 23 May 2007 00:00:00 EST
• 12-Month Study Demonstrated Tolerability and Efficacy of Daytrana™
  published on Wed, 23 May 2007 00:00:00 EST
• Shire Announces Positive Results Of Studies With Guanfacine ER, An Investigational Nonstimulant Medication Filed For The Treatment Of Adhd In Children And Adolescents
  published on Wed, 23 May 2007 00:00:00 EST
• VYVANSE™ receives final DEA classification, first Prodrug Stimulant for treatment of ADHD
  published on Thu, 03 May 2007 11:16:00 EST
• Shire and New River Pharmaceuticals Announce FDA Approval of the First and Only Stimulant Prodrug VYVANSE ™
  published on Fri, 23 Feb 2007 12:00:00 EST
• ADHD Expert Conducting National Worklplace Wellness Seminars
  published on Thu, 30 Nov 2006 12:00:00 EST
• Shire Announces Results of a Meta-Analysis Comparing Stimulant Medications to Non-Stimulant Medications in Treating ADHD in Patients Aged 8 to 15
  published on Thu, 16 Nov 2006 04:45:00 EST
• Shire Announces Results of its Bioequivalence Study of SPD465, an Investigational Drug for Adults with ADHD
  published on Thu, 16 Nov 2006 04:45:00 EST
• Shire Announces Study Results with Once-Daily Guanfacine Extended Release (GXR) In ADHD Patients Aged 6-17
  published on Thu, 16 Nov 2006 04:45:00 EST
• Shire Announces Study Results for Investigational Drug (SPD465) Designed To Reduce Symptoms For Up to 16 Hours
  published on Tue, 31 Oct 2006 00:00:00 EST
• Interim Results of a Phase III Trial of Lisdexamfetamine Dimesylate (NRP104/LDX) in ADHD Presented at Major Scientific Meeting
  published on Mon, 30 Oct 2006 00:00:00 EST
• ADHD Patch Daytrana Effective in Patients Converted From Oral Long-Acting Methylphenidate
  published on Fri, 27 Oct 2006 06:30:00 EST
• Many Adults With Psychiatric Disorders May Also Have Undiagosed ADHD
  published on Fri, 27 Oct 2006 00:00:00 EST
• Celebrity Designer Ty Pennington To Host ADHD Experts On Call Program
  published on Wed, 13 Sep 2006 09:00:00 EDT
• Positive Study Results for Daytrana™ (methylphenidate transdermal system) Presented at a Major Medical Meeting
  published on Wed, 24 May 2006 12:00:00 EDT
• Mixed Amphetamine Salts Extended Release Improves Speed and accuracy of Information Processing in Adults with ADHD
  published on Wed, 24 May 2006 12:00:00 EDT
• Positive Study Results for NRP104 Presented at American Psychiatric Association Meeting
  published on Wed, 24 May 2006 12:00:00 EDT

Other ADHD News

top . send to friend

Reviewed: 07/2008